Skip to main navigation Skip to search Skip to main content

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

  • John Rossi
  • , Patrick Paczkowski
  • , Yueh Wei Shen
  • , Kevin Morse
  • , Brianna Flynn
  • , Alaina Kaiser
  • , Colin Ng
  • , Kyle Gallatin
  • , Tom Cain
  • , Rong Fan
  • , Sean Mackay
  • , James R. Heath
  • , Steven A. Rosenberg
  • , James N. Kochenderfer
  • , Jing Zhou
  • , Adrian Bot

Research output: Contribution to journal › Article › peer-review

286 Scopus citations

Abstract

After treatment with chimeric antigen receptor (CAR) T cells, interleukin-15 (IL-15) elevation and CAR T-cell expansion are associated with non-Hodgkin lymphoma (NHL) outcomes. However, the association of preinfusion CAR product T-cell functionality with clinical outcomes has not been reported. A single-cell analysis of the preinfusion CD19 CAR product from patients with NHL demonstrated that CAR products contain polyfunctional T-cell subsets capable of deploying multiple immune programs represented by cytokines and chemokines, including interferon-g, IL-17A, IL-8, and macrophage inflammatory protein 1a. A prespecified T-cell polyfunctionality strength index (PSI) applied to preinfusion CAR product was significantly associated with clinical response, and PSI combined with CAR T-cell expansion or pretreatment serum IL-15 levels conferred additional significance. Within the total product cell population, associations with clinical outcomes were greater with polyfunctional CD41 T cells compared with CD81 cells. Grade ‡3 cytokine release syndrome was associated with polyfunctional T cells, and both grade ‡3 neurologic toxicity and antitumor efficacy were associated with polyfunctional IL-17A–producing T cells. The findings in this exploratory study show that a preinfusion CAR product T-cell subset with a definable polyfunctional profile has a major association with clinical outcomes of CAR T-cell therapy. This trial was registered at www.clinicaltrials.gov as #NCT00924326.

Original languageEnglish
Pages (from-to)804-814
Number of pages11
JournalBlood
Volume132
Issue number8
DOIs
StatePublished - Aug 23 2018

Fingerprint

Dive into the research topics of 'Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL'. Together they form a unique fingerprint.

Cite this